Marek's disease viral interleukin-8 promotes lymphoma formation through targeted recruitment of B cells and CD4 + CD25 + T Cells

Journal of Virology

Volumn 86, Issue 16, 2012, Pages 8536-8545

  Engel, Annemarie T ^a   Selvaraj, Ramesh K ^b   Kamil, Jeremy P ^c   Osterrieder, Nikolaus ^a   Kaufer, Benedikt B ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b OHIO STATE UNIVERSITY   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CARCINOGENESIS; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; EMBRYO; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE MIGRATION; LYMPHOMA; MAREK DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; START CODON; VIRUS CARCINOGENESIS; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSFORMATION;

ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CHEMOTAXIS; CHICKENS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOMA; MARDIVIRUS; MAREK DISEASE; ONCOGENE PROTEINS, VIRAL; PROTEIN SORTING SIGNALS; SEQUENCE DELETION; VIRULENCE FACTORS;

EID: 84865067682     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00556-12     Document Type: Article

References (42)

1. Anobile JM, et al. 2006. Nuclear localization and dynamic properties of the Marek's disease virus oncogene products Meq and Meq/vIL8. J. Virol. 80:1160-1166.
2. Ausländer S. 2007. Aufreinigung und Charakterisierung monoklonaler Antikörper gegen Ochratoxin B. Bachelor's thesis. Universität Konstanz, Constance, Germany.
3. Baaten BJ, et al. 2009. Early replication in pulmonary B cells after infection with Marek's disease herpesvirus by the respiratory route. Viral Immunol. 22:431-444.
4. Baigent SJ, Smith LP, Nair VK, Currie RJ. 2006. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection. Vet. Immunol. Immunopathol. 112:78-86.
5. Brown AC, et al. 2006. Interaction of MEQ protein and C-terminalbinding protein is critical for induction of lymphomas by Marek's disease virus. Proc. Natl. Acad. Sci. U. S. A. 103:1687-1692.
6. Brown AC, et al. 2009. Homodimerization of the Meq viral oncoprotein is necessary for induction of T-cell lymphoma by Marek's disease virus. J. Virol. 83:11142-11151.
7. Burgess SC, Davison TF. 2002. Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37. J. Virol. 76:7276-7292.
8. Burgess SC, et al. 2004. Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30). Proc. Natl. Acad. Sci. U. S. A. 101:13879-13884.
9. Calnek BW. 1986. Marek's disease-a model for herpesvirus oncology. Crit. Rev. Microbiol. 12:293-320.
10. Calnek BW. 2001. Pathogenesis of Marek's disease virus infection. Curr. Top. Microbiol. Immunol. 255:25-55.
11. Calnek BW, Schat KA, Ross LJ, Shek WR, Chen CL. 1984. Further characterization of Marek's disease virus-infected lymphocytes. I. In vivo infection. Int. J. Cancer 33:389-398.
12. Cui X, Lee LF, Reed WM, Kung HJ, Reddy SM. 2004. Marek's disease virus-encoded vIL-8 gene is involved in early cytolytic infection but dispensable for establishment of latency. J. Virol. 78:4753-4760.
13. Guinamard R, et al. 1999. B cell antigen receptor engagement inhibits stromal cell-derived factor (SDF)-1alpha chemotaxis and promotes protein kinase C (PKC)-induced internalization of CXCR4. J. Exp. Med. 189: 1461-1466.
14. Gunn MD, et al. 1998. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391:799-803.
15. Hamroun D, Desmet F, Lalande M. 2010. Human Splicing Finder, version 2.4.1. http://www.umd.be/HSF/.
16. Jarosinski K, Kattenhorn L, Kaufer B, Ploegh H, Osterrieder N. 2007. A herpesvirus ubiquitin-specific protease is critical for efficient T cell lymphoma formation. Proc. Natl. Acad. Sci. U. S. A. 104:20025-20030.
17. Jarosinski KW, et al. 2007. Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC. J. Virol. 81:10575-10587.
18. Jarosinski KW, Osterrieder N, Nair VK, Schat KA. 2005. Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a. J. Virol. 79:11647-11659.
19. Jarosinski KW, Schat KA. 2007. Multiple alternative splicing to exons II and III of viral interleukin-8 (vIL-8) in the Marek's disease virus genome: the importance of vIL-8 exon I. Virus Genes 34:9-22.
20. Jarosinski KW, Tischer BK, Trapp S, Osterrieder N. 2006. Marek's disease virus: lytic replication, oncogenesis and control. Expert Rev. Vaccines 5:761-772.
21. Kaiser P, et al. 2005. A genomic analysis of chicken cytokines and chemokines. J. Interferon Cytokine Res. 25:467-484.
22. Kaiser P, et al. 2009. Prospects for understanding immune-endocrine interactions in the chicken. Gen. Comp. Endocrinol. 163:83-91.
23. Kaufer BB, Jarosinski KW, Osterrieder N. 2011. Herpesvirus telomeric repeats facilitate genomic integration into host telomeres and mobilization of viral DNA during reactivation. J. Exp. Med. 208:605-615.
24. Levy AM, et al. 2005. Marek's disease virus Meq transforms chicken cells via the v-Jun transcriptional cascade: a converging transforming pathway for avian oncoviruses. Proc. Natl. Acad. Sci. U. S. A. 102:14831-14836.
25. Liu JL, Ye Y, Lee LF, Kung HJ. 1998. Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serumindependent growth, and inhibition of apoptosis. J. Virol. 72:388-395.
26. Lupiani B, et al. 2004. Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc. Natl. Acad. Sci. U. S. A. 101:11815-11820.
27. Negrete OA, et al. 2005. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 436:401-405.
28. Osterrieder N. 1999. Sequence and initial characterization of the U(L)10 (glycoprotein M) and U(L)11 homologous genes of serotype 1 Marek's disease virus. Arch. Virol. 144:1853-1863.
29. Osterrieder N, Kamil JP, Schumacher D, Tischer BK, Trapp S. 2006. Marek's disease virus: from miasma to model. Nat. Rev. Microbiol. 4:283-294.
30. Parcells MS, et al. 2001. Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J. Virol. 75:5159-5173.
31. Qian Z, Brunovskis P, Lee L, Vogt PK, Kung HJ. 1996. Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein. J. Virol. 70:7161-7170.
32. Qian Z, Brunovskis P, Rauscher F, III, Lee L, Kung HJ. 1995. Transactivation activity of Meq, a Marek's disease herpesvirus bZIP protein persistently expressed in latently infected transformed T cells. J. Virol. 69: 4037-4044.
33. Schat KA, Calnek BW, Fabricant J. 1981. Influence of the bursa of Fabricius on the pathogenesis of Marek's disease. Infect. Immun. 31:199-207.
34. Schumacher D, Tischer BK, Fuchs W, Osterrieder N. 2000. Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J. Virol. 74:11088-11098.
35. Schumacher D, Tischer BK, Trapp S, Osterrieder N. 2005. The protein encoded by the US3 orthologue of Marek's disease virus is required for efficient de-envelopment of perinuclear virions and involved in actin stress fiber breakdown. J. Virol. 79:3987-3997.
36. Shack LA, Buza JJ, Burgess SC. 2008. The neoplastically transformed (CD30hi) Marek's disease lymphoma cell phenotype most closely resembles T-regulatory cells. Cancer Immunol. Immunother. 57:1253-1262.
37. Shanmugasundaram R, Selvaraj RK. 2011. Regulatory T cell properties of chicken CD4+CD25+ cells. J. Immunol. 186:1997-2002.
38. Staeheli P, Puehler F, Schneider K, Gobel TW, Kaspers B. 2001. Cytokines of birds: conserved functions-a largely different look. J. Interferon Cytokine Res. 21:993-1010.
39. Tischer BK, et al. 2005. High-level expression of Marek's disease virus glycoprotein C is detrimental to virus growth in vitro. J. Virol. 79:5889-5899.
40. Tischer BK, von Einem J, Kaufer B, Osterrieder N. 2006. Two-step red-mediated recombination for versatile high-efficiency markerlessDNA manipulation in Escherichia coli. Biotechniques 40:191-197.
41. Van de Walle GR, May ML, Sukhumavasi W, von Einem J, Osterrieder N. 2007. Herpesvirus chemokine-binding glycoprotein G (gG) efficiently inhibits neutrophil chemotaxis in vitro and in vivo. J. Immunol. 179: 4161-4169.
42. Witter RL, Calnek BW, Buscaglia C, Gimeno IM, Schat KA. 2005. Classification of Marek's disease viruses according to pathotype: philosophy and methodology. Avian Pathol. 34:75-90.